Polyomavirus BK-specific immunity after kidney transplantation

被引:97
作者
Comoli, P
Azzi, A
Maccario, R
Basso, S
Botti, G
Basile, G
Fontana, L
Labirio, M
Cometa, A
Poli, F
Perfumo, F
Locatelli, F
Ginevri, F
机构
[1] IRCCS, Policlin S Matteo, Lab Sperimentale Trapianto Midollo Osseo & Oncoem, I-27100 Pavia, Italy
[2] Univ Florence, Dept Publ Hlth, Florence, Italy
[3] Ist Giannina Gaslini, Pediat Nephrol Unit, I-16148 Genoa, Italy
[4] San Martino Hosp, Dept Transplant, Genoa, Italy
[5] IRCCS, Maggiore Hosp, Transplant Immunol & Blood Transfus Ctr, Milan, Italy
关键词
kidney transplantation; polyomavirus BK infection; cellular immunity; IFN-gamma-secreting lymphocytes; serology;
D O I
10.1097/01.TP.0000137932.44791.D3
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Failure to mount or maintain a protective immune response may influence the development of polyomavirus BK (BKV)-associated nephropathy (PVAN). However, limited data are so far available on BKV-specific immunity after kidney transplantation. BKV-specific cellular immune response was retrospectively analyzed in kidney recipients with or without BKV infection/reactivation by measuring the frequency of interferon (IFN)-gamma-secreting cells in peripheral blood. Patients with BKV-active infection and good renal function (n=6) had a mean BKV-specific lymphocyte frequency 2 log lower than healthy controls and in the same range as BKV-seropositive recipients without active infection (n=7). Patients with PVAN (n=5) revealed undetectable levels of BKV-specific cells. However, two patients from the latter cohort treated with immunosuppression reduction showed the emergence of specific immunity, with IFN-gamma production in the same range as healthy controls. Our preliminary data suggest that lack of protective immunity toward BKV may favor the occurrence of BKV active infection and influence the progression to PVAN.
引用
收藏
页码:1229 / 1232
页数:4
相关论文
共 18 条
  • [1] Dendritic cells pulsed with polyomavirus BK antigen induce ex vivo polyoma BK virus-specific cytotoxic T-Cell lines in seropositive healthy individuals and renal transplant recipients
    Comoli, P
    Basso, S
    Azzi, A
    Moretta, A
    De Santis, R
    Del Galdo, F
    De Palma, R
    Valente, U
    Nocera, A
    Perfumo, F
    Locatelli, F
    Maccario, R
    Ginevri, F
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2003, 14 (12): : 3197 - 3204
  • [2] Morphological spectrum of polyoma virus disease in renal allografts: Diagnostic accuracy of urine cytology
    Drachenberg, RC
    Drachenberg, CB
    Papadimitriou, JC
    Ramos, E
    Fink, JC
    Wali, R
    Weir, MR
    Cangro, CB
    Klassen, DK
    Khaled, A
    Cunningham, R
    Bartlett, ST
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2001, 1 (04) : 373 - 381
  • [3] CELL-MEDIATED IMMUNE-RESPONSES TO BK VIRUS IN NORMAL INDIVIDUALS
    DRUMMOND, JE
    SHAH, KV
    DONNENBERG, AD
    [J]. JOURNAL OF MEDICAL VIROLOGY, 1985, 17 (03) : 237 - 247
  • [4] Polyomavirus BK infection in pediatric kidney-allograft recipients: A single-center analysis of incidence, risk factors, and novel therapeutic approaches
    Ginevri, F
    de Santis, R
    Comoli, P
    Pastorino, N
    Rossi, C
    Botti, G
    Fontana, I
    Nocera, A
    Cardillo, M
    Ciardi, MR
    Locatelli, F
    Maccario, R
    Perfumo, F
    Azzi, A
    [J]. TRANSPLANTATION, 2003, 75 (08) : 1266 - 1270
  • [5] GRUNDY JE, 1987, LANCET, V2, P996
  • [6] EPSTEIN-BARR VIRUS, IMMUNODEFICIENCY, AND B-CELL LYMPHOPROLIFERATION
    HANTO, DW
    FRIZZERA, G
    GAJLPECZALSKA, KJ
    SIMMONS, RL
    [J]. TRANSPLANTATION, 1985, 39 (05) : 461 - 472
  • [7] Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients
    Hirsch, HH
    Knowles, W
    Dickenmann, M
    Passweg, J
    Klimkait, T
    Mihatsch, MJ
    Steiger, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2002, 347 (07) : 488 - 496
  • [8] Polyomavirus BK
    Hirsch, HH
    Steiger, J
    [J]. LANCET INFECTIOUS DISEASES, 2003, 3 (10) : 611 - 623
  • [9] Association of prolonged survival in HLA-A2+ progressive multifocal leukoencephalopathy patients with a CTL response specific for a commonly recognized JC virus epitope
    Koralnik, IJ
    Du Pasquier, RA
    Kuroda, MJ
    Schmitz, JE
    Dang, X
    Zheng, Y
    Lifton, M
    Letvin, NL
    [J]. JOURNAL OF IMMUNOLOGY, 2002, 168 (01) : 499 - 504
  • [10] JC virus-specific cytotoxic T lymphocytes in individuals with progressive multifocal leukoencephalopathy
    Koralnik, IJ
    Du Pasquier, RA
    Letvin, NL
    [J]. JOURNAL OF VIROLOGY, 2001, 75 (07) : 3483 - 3487